Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.46 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | CASP3 | P42574 | 2/20 | 0.45 |
| ▸ | MDM4 | O15151 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1800381 | 0.83 | KMT2A (0.64) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL30238049 | 0.83 | KMT2A (0.64) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL3757636 | 0.82 | KMT2A (0.72) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL402111 | 0.82 | KMT2A (0.68) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL13613350 | 0.82 | KMT2A (0.72) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL21332462 | 0.81 | KMT2A (0.66) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL25037329 | 0.79 | KMT2A (0.64) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL4225816 | 0.79 | KMT2A (0.68) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL29223688 | 0.79 | KMT2A (0.59) | KMT2AEPHX2FABP5FABP7CASP3 | |
| SCHEMBL12235815 | 0.79 | KMT2A (0.64) | KMT2AEPHX2FABP5FABP7CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1513811-A1 | NON-PEPTIDIC BRS-3 AGONISTS | Solvay Pharmaceuticals GmbH (DE) | 2005-03-16 | — | — | EP | disclosed |
| WO-2003104196-A1 | NON-PEPTIDIC BRS-3 AGONISTS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2003-12-18 | — | — | WO | disclosed |